Mortality after Liver Resection

29
Jacques Belghiti Silvio Balzan, Fabien Stenard, Satoshi Ogata Department of Hepato-Pancreatico-Biliary and United Federation of Hepato-Gastroenterology and Digestive Surgery of Beaujon Hospital, Clichy, University Paris 7. France Mortality after Liver Resection

description

Mortality after Liver Resection. Jacques Belghiti Silvio Balzan, Fabien Stenard, Satoshi Ogata. Department of Hepato-Pancreatico-Biliary and United Federation of Hepato-Gastroenterology and Digestive Surgery of Beaujon Hospital, Clichy, University Paris 7. France. - PowerPoint PPT Presentation

Transcript of Mortality after Liver Resection

Jacques BelghitiSilvio Balzan, Fabien Stenard, Satoshi Ogata

Department of Hepato-Pancreatico-Biliary and United Federation of Hepato-Gastroenterology and Digestive Surgery of Beaujon

Hospital, Clichy, University Paris 7. France

Mortality after Liver Resection

427 Resection of HCC: 1990 - 2003

Normal Chronic Liver

Liver Disease

Mortality 1.2% 7.7%

•Bleeding 2% 8%•Ascites 15% 45%•Jaundice 4% 12%•Infection 15% 25%•Renal failure 0% 8%•Liver Failure 0.5% 6%

Absence or insufficient liver regeneration

0 10 20 30 40

1

3

5

7

9

11

13

15

17

19

21

23

25

Post Operative Days

Early post operative deaths within 3 days•Myocardiac infarction (n = 1)•Peritonitis due to bowel necrosis (n = 2)

In-Hospital Mortality (n = 26) 3.3%Median post operative deaths

POD 16 (range 5-39)

Elective Liver Resectionn = 775 (1998 – 2002)

Liver Parenchymal Status

0 10 20 30 40

1

3

5

7

9

11

13

15

17

19

21

23

Post Operative Days

Normal (n = 5)

Disead (n = 18) 78%

Severe Infection or Renal Failure

0 10 20 30 40

1

3

5

7

9

11

13

15

17

19

21

23

Post Operative Days

Incidence: 74%Median POD: 10 (range 2-18)

Occurrence before or at POD 5: 30 %

In Hospital Deaths (n = 26)

0 10 20 30 40

1

3

5

7

9

11

13

15

17

19

21

23

25

Post Operative Days

Early post operative deaths within 3 days•Myocardiac infarction (n = 1)•Peritonitis due to bowel necrosis (n = 2)

Median post operative deathsLink to liver FailurePOD 16 (range 5-39)

• Postoperative Liver Failure remains the most dangerous complication after Liver Resection

• Risk of Death – Insufficient absolute or functional liver parenchyma. – Impaired tolerance to infectious complications.

•Definition ?

•Prevalence ?

•Impact on postoperative mortality ?

What is Post operative Liver Failure ?

Clinical Biological- Encephalopathy - Bilirubinemia > 150 µmol/L- Jaundice - PT < 50% - - Ascites - Factor V < 50% - ICG 15 min > 20 or 15%

• Encephalopathy, ascites or coagulopathy requering specific treatment. Hemming AW et al. Ann Surg 2003,5:686-93.

• Prolonged hyperbilirubinemia, ascites,coagulopathy requering fresh-frozen plasma, and/or encephalopathy. Jarnagin WR et al. Ann Surg 2003,4:397-407.

• Bilirubinemia > 5 mg/dL (85 µmol/L), PT < 50% for 3 or more consecutive days. Imamura H. Arch Surg 2003,138:1198-1206.

• Two of Bilirubinemia >60 µmol/L, asterixis, and prothrombin time<30%. Azoulay D. Ann Surg 2000,232:665-72

Objective

Criteria of Post operative Liver Failure

predicting high mortality rate.

–Simple: quick, cheap and non invasive.

–Efficient: allowing early diagnosis and early management.

–Standardized: compare results.

FIFTY-FIFTY AT DAY FIVE CRITERIA

Child-Pugh Score

Encephalopathy absent controlled medically poorly controlled

Ascites absent controlled medically poorly controlled

Albumin (g/l) > 35 28 – 35 < 28

Serum Bilirubin (µmol/l) < 35 35 – 50 > 50

Prothrombin Time (%) > 50 40 – 50 < 40

Peri-operative risk assessment in cirrhosis:

Child-Pugh Score: Criteria of POLF

•Encephalopathy poorly controlled

•Ascites poorly controlled

•Albumin (g/l) < 28

•Serum Bilirubin (µmol/l) > 50

•Prothrombin Time (%) < 50

Post operative period

⇨ Not applicable (anesthesia)

⇨ Frequent after liver resection

⇨ Useless (post. hemodiluition)

⇨ When ?

⇨ When ?

Liver Tests after Major Hepatectomy

50

55

60

65

70

75

80

85

90

95

100

105

TPj-1 TPj1 TPj3 TPj5 TPj7 TPj9 TPj115

10

15

20

25

30

35

40

Bbj-1 Bbj1 Bbj3 Bbj5 Bbj7 Bbj9 Bbj11

40

60

80

100

120

140

160

180

200

GG

TJ-

1

GG

TJ1

GG

TJ3

GG

TJ5

GG

TJ7

GG

TJ9

GG

TJ1

1

0

50

100

150

200

250

300

350

ASTj-1 ASTj1 ASTj3 ASTj5 ASTj7 ASTj9 ASTj110

50

100

150

200

250

300

350

ALTj-1 ALTj1 ALTj3 ALTj5 ALTj7 ALTj9 ALTj11100

110

120

130

140

150

160

170

180

190

200

210

PAj-1 PAj1 PAj3 PAj5 PAj7 PAj9 PAj11

Prothrombin Time Bilirubinemia GGT

ASAT ALAT ALP

Prospective Database from 1998 – 2002

775 elective liver resection*

• Aged: 54 ± 10 years• Malignant tumors: 531 (69%)• Major resection: 464 (60%)

• Diseased Liver present: 307 (40%)– Fibrosis 237 (31%)– Cirrhosis 94 (12%)– Steatosis >30%: 107 (14%)

• In hospital mortality: (n=26) 3.3%

Postoperative Liver Tests1998 – 2002: 775 elective liver resection

30

40

50

60

70

80

90

100

110

-2 -1 0 1 2 3 4 5 6 7 8

Postoperative Day

Pro

thro

mb

in T

ime (

% o

f n

orm

al)

10

15

20

25

30

35

40

45

Seru

m T

ota

l B

ilir

ub

in (

µm

ol/

L)

In Hospital Deaths (n = 26)

0 10 20 30 40

1

3

5

7

9

11

13

15

17

19

21

23

25

Post Operative Days

Median post operative deathsLink to liver FailurePOD 16 (range 5-39)

Postoperative Morbidity vs No Complications

40

50

60

70

80

90

100

110

TPj-1 TPj1 TPj3 TPj5 TPj7 TPj9 TPj11

0

20

40

60

80

100

120

Bbj-1 Bbj1 Bbj3 Bbj5 Bbj7 Bbj9 Bbj11

0

50

100

150

200

250

300

350

400

ASTj-1 ASTj1 ASTj3 ASTj5 ASTj7 ASTj9 ASTj1180

100

120

140

160

180

200

220

PAj-1 PAj1 PAj3 PAj5 PAj7 PAj9 PAj11

ALP

PT Bilirubinemia

ASAT

50

55

60

65

70

75

80

85

90

95

100

105

TPj-1 TPj1 TPj3 TPj5 TPj7 TPj9 TPj11

Prothrombin Time (%)

PT < 50% 1 3 5 7

Incidence 21% 16% 6% 4%

Mortality if present 10% 16% 33% 40%

absent 1.5 % 1.3 % 1.3 % 1%

5

10

15

20

25

30

35

40

Bbj-1 Bbj1 Bbj3 Bbj5 Bbj7 Bbj9 Bbj11

Bilirubinemia

> 50 µml/L 1 3 5 7

Incidence 17% 19% 16% 11%

Mortality if present 7% 11% 15% 17%

absent 2 % 2 % 1 % 1%

30

40

50

60

70

80

90

100

110

-2 -1 0 1 2 3 4 5 6 7 8

Postoperative Day

Pro

thro

mb

in T

ime (

% o

f n

orm

al)

10

15

20

25

30

35

40

45

Seru

m T

ota

l B

ilir

ub

in (

µm

ol/

L)

Mortality day 5

PT < 50% 33%SB > 50 µml/L 15%

PT<50% and SB>50 µml/L 59%

Fifty – Fifty at day Five Criteria after Hepatectomy

59 %4 %Bil > 50 µmol/L

7 %1 %Bil < 50 µmol/L

PT <50%PT >50%DAY 5

Mortality according to PT< 50% and Bilirubinemia >50 µmol/L

25 Patients with 50-50 criteria

•14 deaths 11 Severe Morbidity

ICU : 22 days (4 – 57)

Hospital stay: 43 days (17 –

69)-Dead without 50-50 criteria at day 5 (n=7)

3 digestive bleeding with portal thrombosis 2 biliar peritonites and septicemia by candida4 severe sepsis

Conclusions

The presence at day 5 of the criteria 50 – 50 (PT< 50% and Bilirubinemia > 50 µmol/L) is an early and strong predictor (60%) of mortality

“50-50 criteria”•At day 5 the criteria 50 – 50 (PT< 50% and Bilirubinemia > 50 µmol/L) which is an early and strong predictor (60%) of mortality can be used as a criteria of Postoperative Liver Failure.

•Most importantly, this criteria which precede any clinical evidence of complication and death by a median of 5 and 10 days can be used for:

– early assessment of infection or portal thrombosis and

– to implement specific therapeutic interventions such as prophylactic antimicrobial therapy, artificial liver support or even liver transplantation.

Case75 yrs male30/03/2004 Right hemicolectomy Dukes C, 2 metastases in right liver - 12/2004 Systemic chemotherapy (Oxaliplatin+5FU+LV)10/02/2005 Right hepatectomy Labo dataAST: 43 IU/LALT: 66 IU/LGGT: 248 IU/L T-Bil: 5 µmol/LPT: 76%

10

20

30

40

50

60

70

80

-2 -1 0 1 2 3 4 5 6 7 8 9 10

Postoperative Day

Pro

thro

mb

in T

ime

(% o

f n

orm

al)

0

50

100

150

200

Ser

um

To

tal

Bil

iru

bin

mo

l/L

)

Death

MARS

PT

Bil

FIFTY-FIFTY AT DAY FIVE CRITERIA

-Dead with 50-50 criteria at day 5 present

1 no context of liver failure12 infected ascites – portal thrombosis

pneumopathy

-Dead without 50-50 criteria at day 5

3 digestive bleeding – biliar peritonitessepticemia by candida

7 portal thrombosis – infected ascites (3)

-No dead despite 50-50 criteria present

3 transient criteria (only at day 5) – uncomplicated outcome9 100% of morbidity

USI 22 days (4 - 57)Hospitalization 43 days (17 - 69)

FIFTY-FIFTY AT DAY FIVE CRITERIA

-Deaths without 50-50 criteria at day 5

3 digestive bleeding biliar peritonitessepticemia with candida

7 portal thrombosis infected ascites (3)

Prothrombin Time (%)

50

55

60

65

70

75

80

85

90

95

100

105

TPj-1 TPj1 TPj3 TPj5 TPj7 TPj9 TPj11

Bilirubinemia

5

10

15

20

25

30

35

40

Bbj-1 Bbj1 Bbj3 Bbj5 Bbj7 Bbj9 Bbj11